Add Yahoo as a preferred source to see more of our stories on Google. Cancer remains one of humanity's most formidable challenges, claiming the lives of millions every year despite decades of medical ...
Immuneering has reported updated data on atebimetinib in first-line pancreatic cancer patients, linking the MEK inhibitor to 64% overall survival (OS) at 12 months. The update is the latest cut of ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Cystic adenocarcinoma (marked in red) of the pancreas (outlined in green). Contrast‑enhanced ...
Adding the investigational drug elraglusib to standard first-line gemcitabine and nab-paclitaxel (GnP) may extend the lives of some patients with metastatic pancreatic ductal adenocarcinoma (PDAC), ...
The MarketWatch News Department was not involved in the creation of this content. Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News ...
Among older adults with pancreatic ductal adenocarcinoma (PDAC), prediagnosis diabetes was associated with shorter survival, but BMI and physical activity throughout adulthood showed no relationship ...
Pancreatic cancer is not a disease that reveals itself easily, at least not initially. The pancreas is tucked deep in the abdomen, behind the stomach, so tumours aren’t easy to see or feel. A person ...
A Mayo Clinic study is providing new insights into how treatment sequence can affect survival in patients with early-stage pancreatic cancer, suggesting that many patients may benefit from receiving ...
Please provide your email address to receive an email when new articles are posted on . Vaccine could improve survival for patients with pancreatic and colorectal cancers. Vaccine targets mutant KRAS ...
Cancer statistics have reached new heights — in good and not-so-good ways. The American Cancer Society (ACS) released its annual report on cancer trends this week, showing for the first time that more ...
Jean Trebek, Lisa Swayze, Joan Vassos, Stephen Nichols, Jeff Mauro, Jonathan Frakes, Kitty Swink, Rosa Blasi and Many More Raise [...] READ MORE ...
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Scientists developed an antibody treatment that reawakens the immune system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results